|
8:00- 9:00
|
Registration and Coffee
|
|
Congress opening and greetings
Session A
Chairs: Dr. Malena Cohen-Cymberknoh, MD and Dr. Michal Shteinberg, MD, PhD
(Session conducted in English)
|
|
9:00- 9:10
|
Welcome and introduction
Malena Cohen-Cymberknoh, MD; CF Center, Hadassah Medical Center, Jerusalem
|
|
9:10- 9:25
|
Meconium ileus in CF-PS
Michael Wilschanski, MD; CF Center, Hadassah Medical Center, Jerusalem
|
|
9:25- 9:40
|
Nutritional status in childhood and lung function in adulthood
Moshe Ashkenazi, MD; The National Center for CF, Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer
|
|
9:40- 09:55
|
Correlation between Lung Clearance Index (LCI) and CF severity markers
Elad Ben Meir, MD; CF Center, Hadassah Medical Center, Jerusalem
|
|
9:55- 10:10
|
Six-minute walk test, LCI and QOL in CF and BO
Michal Gur, MD; CF Center Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa
|
|
10:10-10:25
|
The effect of inhaling a β2-agonist, prior to respiratory physiotherapy, on lung function of Cystic Fibrosis Subjects
Daphna Vilozni, PhD: The National Center for CF, Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer
|
|
10:25- 10:40
|
Investigating CF in adult patients with bronchiectasis
Michal Shteinberg, MD, PhD; CF Center, Carmel Medical Center, Haifa &
Adi Dagan, MD; The National Center for CF, Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer
|
|
10:40-11:15
|
Coffee Break
|
|
Session B
Chairs: Dr. David Shoseyov, MD and Dr. Moshe Ashkenazi, MD
(Session conducted in English)
|
|
11:15-11:30
|
Long-term IV antibiotics using a peripheral line - is this possible?
Yulia Gendler, RN; Graub CF Center, Schneider Children's Medical Center, Petah Tikva
|
|
11:30-11:45
|
Is there still a role for selected bronchoscopy in CF?
Alex Gileles-Hillel, MD; CF Center, Hadassah Medical Center, Jerusalem
|
|
11:45-12:00
|
Diagnostic value of sputum cultures in children under two years of age with chronic lung disease
Gal Zaks, MD; Graub CF Center, Schneider Children's Medical Center,
Petah Tikva
|
|
12:00-12:15
|
Identification and monitoring of early lung disease: how aggressive should we be?
Eitan Kerem, MD; CF Center, Hadassah Medical Center, Jerusalem
|
|
12:15-14:00
|
Lunch
|
|
Session C
Chairs: Dr. Huda Georgy Mussaffi, MD and Dr. Dario Prais, MD
(Session conducted in English)
|
|
14:00- 14:30
|
Special Lecture
CF- Past, present and future
Hannah Blau, MBBS; Graub CF Center, Schneider Children's Medical Center, Petah Tikva
|
|
14:30- 14:50
|
New and future therapies for CF
Malena Cohen-Cymberknoh, MD; CF Center, Hadassah Medical Center, Jerusalem
|
|
14:50- 15:10
|
From double to triple combination CFTR modulators
Dario Prais, MD; Graub CF Center, Schneider Children's Medical Center, Petah Tikva
|
|
15:10- 15:30
|
Ivacaftor for patients with residual function mutations in Israel:Update on the VX16-770-127 study
Thea Pugatsch, PhD; CF Center, Hadassah Medical Center, Jerusalem
|
|
15:30- 16:00
|
Coffee Break and Exhibition
|
|
Session D
Chairs: Prof. Batsheva Kerem, PhD and Prof. Lea Bentur, MD
(Session conducted in English)
|
|
16:00- 16:20
|
Restoration of CFTR function by antisense oligonucleotide splicing modulation
Batsheva Kerem, PhD; Life Sciences Institute, Hebrew University, Jerusalem
|
|
16:20- 16:45
|
Developing CFTR modulators for rare and hard-to-treat mutations
Alan S. Verkman, MD, PhD; UCSF Medical Center, San Francisco, CA
|
|
16:45- 17:10
|
CFTR modulators as therapy for rare mutations
George Solomon, MD; UAB Hospital, Birmingham, Alabama
|
|
17:10- 17:40
|
Genetic modifiers as therapy for Cystic Fibrosis
Garry R Cutting, MD; The Johns Hopkins Hospital, Baltimore, Maryland
|
|
17:40- 18:00
|
The Q359K/T360K mutation causes CF in Georgian Jews
Meir Mei Zahav, MD; Graub CF Center, Schneider Children's Medical Center,
Petah Tikva & Hanoch Senderowitz, PhD; Dep. Chemistry, Bar Ilan University
|